LivaNova Stock Forecast
NASDAQ: LIVNHealth CareBiotechnology: Electromedical & Electrotherapeutic ApparatusUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
LIVN analyst consensus
Consensus (11 analysts)
buy
Avg. price target
$90.55+18.54%
- Strong buy 3
- Buy 6
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 11 Wall Street analysts covering LivaNova (2026-10-11), 9 rate the stock a buy or strong buy, 2 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $90.55, with a high estimate of $105.00 and a low estimate of $75.00. The average target implies upside of 18.5% from the current price of $76.39.
The spread between the highest and lowest targets is 40.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for LIVN.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 3 | 27% |
| Buy | 6 | 55% |
| Hold | 2 | 18% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-11.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $75.00 | -1.82% |
| Average target | $90.55 | +18.54% |
| High target | $105.00 | +37.45% |